カテゴリー： Market Monitor Global, 世界, 医療/バイオ

酵素阻害剤の世界市場見通し2023年-2029年

◆英語タイトル：Enzyme Inhibitors Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5541）

◆商品コード：MMG23JU5541
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：71
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Enzyme Inhibitors Market 調査レポートは次の情報を含め、グローバルにおけるの酵素阻害剤市場規模と予測を収録しています。・世界の酵素阻害剤市場：売上、2018年-2023年、2024年-2029年
・世界の酵素阻害剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の酵素阻害剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「プロトンポンプ阻害剤（PPI）」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

酵素阻害剤のグローバル主要企業は、AstraZeneca、 GlaxoSmithKline、 Bayer、 Novartis、 Roche、 Ranbaxy Laboratories、 Johnson & Johnson、 Abbott Laboratories、 Takeda、 Pfizer、 Sanofi、 Merckなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、酵素阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の酵素阻害剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の酵素阻害剤市場：タイプ別市場シェア、2022年
・プロトンポンプ阻害剤（PPI）、プロテアーゼ阻害剤、逆転写酵素阻害剤、アロマターゼ阻害剤、キナーゼ阻害剤、ノイラミニダーゼ阻害剤、その他

世界の酵素阻害剤市場：用途別、2018年-2023年、2024年-2029年
世界の酵素阻害剤市場：用途別市場シェア、2022年
・病院、研究機関、その他

世界の酵素阻害剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の酵素阻害剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における酵素阻害剤のグローバル売上、2018年-2023年
・主要企業における酵素阻害剤のグローバル売上シェア、2022年
・主要企業における酵素阻害剤のグローバル販売量、2018年-2023年
・主要企業における酵素阻害剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AstraZeneca、 GlaxoSmithKline、 Bayer、 Novartis、 Roche、 Ranbaxy Laboratories、 Johnson & Johnson、 Abbott Laboratories、 Takeda、 Pfizer、 Sanofi、 Merck

*************************************************************

・調査・分析レポートの概要
酵素阻害剤市場の定義
市場セグメント
世界の酵素阻害剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の酵素阻害剤市場規模
世界の酵素阻害剤市場規模：2022年 VS 2029年
世界の酵素阻害剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの酵素阻害剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の酵素阻害剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：プロトンポンプ阻害剤（PPI）、プロテアーゼ阻害剤、逆転写酵素阻害剤、アロマターゼ阻害剤、キナーゼ阻害剤、ノイラミニダーゼ阻害剤、その他
酵素阻害剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、研究機関、その他
酵素阻害剤の用途別グローバル売上・予測

・地域別市場分析
地域別酵素阻害剤市場規模 2022年と2029年
地域別酵素阻害剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AstraZeneca、 GlaxoSmithKline、 Bayer、 Novartis、 Roche、 Ranbaxy Laboratories、 Johnson & Johnson、 Abbott Laboratories、 Takeda、 Pfizer、 Sanofi、 Merck
...

Enzyme inhibitors are naturally occurring molecules that attach to the enzymes to inhibit the culture of harmful pathogens and enhance metabolism. They have varied applications as drugs in therapeutics and pesticides for agricultural activities.
This report aims to provide a comprehensive presentation of the global market for Enzyme Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme Inhibitors. This report contains market size and forecasts of Enzyme Inhibitors in global, including the following market information:
Global Enzyme Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Enzyme Inhibitors Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Enzyme Inhibitors companies in 2022 (%)
The global Enzyme Inhibitors market was valued at US$ 147910 million in 2022 and is projected to reach US$ 155960 million by 2029, at a CAGR of 0.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In recent years, the market has witnessed significant growth owing to outsourcing manufacturing process coupled with effective & accurate therapies for chronic diseases such as cancer, respiratory diseases, and others.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enzyme Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enzyme Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Enzyme Inhibitors Market Segment Percentages, by Type, 2022 (%)
Proton Pump Inhibitors (PPIs)
Protease Inhibitors
Reverse Transcriptase Inhibitors
Aromatase Inhibitors
Kinase Inhibitors
Neuraminidase Inhibitors
Others
Global Enzyme Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Enzyme Inhibitors Market Segment Percentages, by Application, 2022 (%)
Hospital
Research Institution
Others
Global Enzyme Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Enzyme Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enzyme Inhibitors revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Enzyme Inhibitors revenues share in global market, 2022 (%)
Key companies Enzyme Inhibitors sales in global market, 2018-2023 (Estimated), (Units)
Key companies Enzyme Inhibitors sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
GlaxoSmithKline
Bayer
Novartis
Roche
Ranbaxy Laboratories
Johnson & Johnson
Abbott Laboratories
Takeda
Pfizer
Sanofi
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Enzyme Inhibitors, market overview.
Chapter 2: Global Enzyme Inhibitors market size in revenue and volume.
Chapter 3: Detailed analysis of Enzyme Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enzyme Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Enzyme Inhibitors capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Enzyme Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Enzyme Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Enzyme Inhibitors Overall Market Size
2.1 Global Enzyme Inhibitors Market Size: 2022 VS 2029
2.2 Global Enzyme Inhibitors Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Enzyme Inhibitors Sales: 2018-2029
3 Company Landscape
3.1 Top Enzyme Inhibitors Players in Global Market
3.2 Top Global Enzyme Inhibitors Companies Ranked by Revenue
3.3 Global Enzyme Inhibitors Revenue by Companies
3.4 Global Enzyme Inhibitors Sales by Companies
3.5 Global Enzyme Inhibitors Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Enzyme Inhibitors Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Enzyme Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Enzyme Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Enzyme Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Enzyme Inhibitors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Enzyme Inhibitors Market Size Markets, 2022 & 2029
4.1.2 Proton Pump Inhibitors (PPIs)
4.1.3 Protease Inhibitors
4.1.4 Reverse Transcriptase Inhibitors
4.1.5 Aromatase Inhibitors
4.1.6 Kinase Inhibitors
4.1.7 Neuraminidase Inhibitors
4.1.8 Others
4.2 By Type – Global Enzyme Inhibitors Revenue & Forecasts
4.2.1 By Type – Global Enzyme Inhibitors Revenue, 2018-2023
4.2.2 By Type – Global Enzyme Inhibitors Revenue, 2024-2029
4.2.3 By Type – Global Enzyme Inhibitors Revenue Market Share, 2018-2029
4.3 By Type – Global Enzyme Inhibitors Sales & Forecasts
4.3.1 By Type – Global Enzyme Inhibitors Sales, 2018-2023
4.3.2 By Type – Global Enzyme Inhibitors Sales, 2024-2029
4.3.3 By Type – Global Enzyme Inhibitors Sales Market Share, 2018-2029
4.4 By Type – Global Enzyme Inhibitors Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Enzyme Inhibitors Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Research Institution
5.1.4 Others
5.2 By Application – Global Enzyme Inhibitors Revenue & Forecasts
5.2.1 By Application – Global Enzyme Inhibitors Revenue, 2018-2023
5.2.2 By Application – Global Enzyme Inhibitors Revenue, 2024-2029
5.2.3 By Application – Global Enzyme Inhibitors Revenue Market Share, 2018-2029
5.3 By Application – Global Enzyme Inhibitors Sales & Forecasts
5.3.1 By Application – Global Enzyme Inhibitors Sales, 2018-2023
5.3.2 By Application – Global Enzyme Inhibitors Sales, 2024-2029
5.3.3 By Application – Global Enzyme Inhibitors Sales Market Share, 2018-2029
5.4 By Application – Global Enzyme Inhibitors Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Enzyme Inhibitors Market Size, 2022 & 2029
6.2 By Region – Global Enzyme Inhibitors Revenue & Forecasts
6.2.1 By Region – Global Enzyme Inhibitors Revenue, 2018-2023
6.2.2 By Region – Global Enzyme Inhibitors Revenue, 2024-2029
6.2.3 By Region – Global Enzyme Inhibitors Revenue Market Share, 2018-2029
6.3 By Region – Global Enzyme Inhibitors Sales & Forecasts
6.3.1 By Region – Global Enzyme Inhibitors Sales, 2018-2023
6.3.2 By Region – Global Enzyme Inhibitors Sales, 2024-2029
6.3.3 By Region – Global Enzyme Inhibitors Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Enzyme Inhibitors Revenue, 2018-2029
6.4.2 By Country – North America Enzyme Inhibitors Sales, 2018-2029
6.4.3 US Enzyme Inhibitors Market Size, 2018-2029
6.4.4 Canada Enzyme Inhibitors Market Size, 2018-2029
6.4.5 Mexico Enzyme Inhibitors Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Enzyme Inhibitors Revenue, 2018-2029
6.5.2 By Country – Europe Enzyme Inhibitors Sales, 2018-2029
6.5.3 Germany Enzyme Inhibitors Market Size, 2018-2029
6.5.4 France Enzyme Inhibitors Market Size, 2018-2029
6.5.5 U.K. Enzyme Inhibitors Market Size, 2018-2029
6.5.6 Italy Enzyme Inhibitors Market Size, 2018-2029
6.5.7 Russia Enzyme Inhibitors Market Size, 2018-2029
6.5.8 Nordic Countries Enzyme Inhibitors Market Size, 2018-2029
6.5.9 Benelux Enzyme Inhibitors Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Enzyme Inhibitors Revenue, 2018-2029
6.6.2 By Region – Asia Enzyme Inhibitors Sales, 2018-2029
6.6.3 China Enzyme Inhibitors Market Size, 2018-2029
6.6.4 Japan Enzyme Inhibitors Market Size, 2018-2029
6.6.5 South Korea Enzyme Inhibitors Market Size, 2018-2029
6.6.6 Southeast Asia Enzyme Inhibitors Market Size, 2018-2029
6.6.7 India Enzyme Inhibitors Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Enzyme Inhibitors Revenue, 2018-2029
6.7.2 By Country – South America Enzyme Inhibitors Sales, 2018-2029
6.7.3 Brazil Enzyme Inhibitors Market Size, 2018-2029
6.7.4 Argentina Enzyme Inhibitors Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Enzyme Inhibitors Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Enzyme Inhibitors Sales, 2018-2029
6.8.3 Turkey Enzyme Inhibitors Market Size, 2018-2029
6.8.4 Israel Enzyme Inhibitors Market Size, 2018-2029
6.8.5 Saudi Arabia Enzyme Inhibitors Market Size, 2018-2029
6.8.6 UAE Enzyme Inhibitors Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Enzyme Inhibitors Major Product Offerings
7.1.4 AstraZeneca Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Enzyme Inhibitors Major Product Offerings
7.2.4 GlaxoSmithKline Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Enzyme Inhibitors Major Product Offerings
7.3.4 Bayer Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Enzyme Inhibitors Major Product Offerings
7.4.4 Novartis Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Enzyme Inhibitors Major Product Offerings
7.5.4 Roche Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Ranbaxy Laboratories
7.6.1 Ranbaxy Laboratories Company Summary
7.6.2 Ranbaxy Laboratories Business Overview
7.6.3 Ranbaxy Laboratories Enzyme Inhibitors Major Product Offerings
7.6.4 Ranbaxy Laboratories Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.6.5 Ranbaxy Laboratories Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Enzyme Inhibitors Major Product Offerings
7.7.4 Johnson & Johnson Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Enzyme Inhibitors Major Product Offerings
7.8.4 Abbott Laboratories Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.8.5 Abbott Laboratories Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Enzyme Inhibitors Major Product Offerings
7.9.4 Takeda Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.9.5 Takeda Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Enzyme Inhibitors Major Product Offerings
7.10.4 Pfizer Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Sanofi
7.11.1 Sanofi Company Summary
7.11.2 Sanofi Enzyme Inhibitors Business Overview
7.11.3 Sanofi Enzyme Inhibitors Major Product Offerings
7.11.4 Sanofi Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.11.5 Sanofi Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Enzyme Inhibitors Business Overview
7.12.3 Merck Enzyme Inhibitors Major Product Offerings
7.12.4 Merck Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.12.5 Merck Key News & Latest Developments
8 Global Enzyme Inhibitors Production Capacity, Analysis
8.1 Global Enzyme Inhibitors Production Capacity, 2018-2029
8.2 Enzyme Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Enzyme Inhibitors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Enzyme Inhibitors Supply Chain Analysis
10.1 Enzyme Inhibitors Industry Value Chain
10.2 Enzyme Inhibitors Upstream Market
10.3 Enzyme Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Enzyme Inhibitors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Enzyme Inhibitors in Global Market
Table 2. Top Enzyme Inhibitors Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Enzyme Inhibitors Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Enzyme Inhibitors Revenue Share by Companies, 2018-2023
Table 5. Global Enzyme Inhibitors Sales by Companies, (Units), 2018-2023
Table 6. Global Enzyme Inhibitors Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Enzyme Inhibitors Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Enzyme Inhibitors Product Type
Table 9. List of Global Tier 1 Enzyme Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Enzyme Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Enzyme Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Enzyme Inhibitors Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Enzyme Inhibitors Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Enzyme Inhibitors Sales (Units), 2018-2023
Table 15. By Type - Global Enzyme Inhibitors Sales (Units), 2024-2029
Table 16. By Application – Global Enzyme Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Enzyme Inhibitors Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Enzyme Inhibitors Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Enzyme Inhibitors Sales (Units), 2018-2023
Table 20. By Application - Global Enzyme Inhibitors Sales (Units), 2024-2029
Table 21. By Region – Global Enzyme Inhibitors Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Enzyme Inhibitors Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Enzyme Inhibitors Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Enzyme Inhibitors Sales (Units), 2018-2023
Table 25. By Region - Global Enzyme Inhibitors Sales (Units), 2024-2029
Table 26. By Country - North America Enzyme Inhibitors Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Enzyme Inhibitors Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Enzyme Inhibitors Sales, (Units), 2018-2023
Table 29. By Country - North America Enzyme Inhibitors Sales, (Units), 2024-2029
Table 30. By Country - Europe Enzyme Inhibitors Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Enzyme Inhibitors Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Enzyme Inhibitors Sales, (Units), 2018-2023
Table 33. By Country - Europe Enzyme Inhibitors Sales, (Units), 2024-2029
Table 34. By Region - Asia Enzyme Inhibitors Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Enzyme Inhibitors Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Enzyme Inhibitors Sales, (Units), 2018-2023
Table 37. By Region - Asia Enzyme Inhibitors Sales, (Units), 2024-2029
Table 38. By Country - South America Enzyme Inhibitors Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Enzyme Inhibitors Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Enzyme Inhibitors Sales, (Units), 2018-2023
Table 41. By Country - South America Enzyme Inhibitors Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Enzyme Inhibitors Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Enzyme Inhibitors Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Enzyme Inhibitors Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Enzyme Inhibitors Sales, (Units), 2024-2029
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Enzyme Inhibitors Product Offerings
Table 48. AstraZeneca Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Enzyme Inhibitors Product Offerings
Table 52. GlaxoSmithKline Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Enzyme Inhibitors Product Offerings
Table 56. Bayer Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Enzyme Inhibitors Product Offerings
Table 60. Novartis Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Enzyme Inhibitors Product Offerings
Table 64. Roche Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Roche Key News & Latest Developments
Table 66. Ranbaxy Laboratories Company Summary
Table 67. Ranbaxy Laboratories Enzyme Inhibitors Product Offerings
Table 68. Ranbaxy Laboratories Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Ranbaxy Laboratories Key News & Latest Developments
Table 70. Johnson & Johnson Company Summary
Table 71. Johnson & Johnson Enzyme Inhibitors Product Offerings
Table 72. Johnson & Johnson Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Johnson & Johnson Key News & Latest Developments
Table 74. Abbott Laboratories Company Summary
Table 75. Abbott Laboratories Enzyme Inhibitors Product Offerings
Table 76. Abbott Laboratories Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Abbott Laboratories Key News & Latest Developments
Table 78. Takeda Company Summary
Table 79. Takeda Enzyme Inhibitors Product Offerings
Table 80. Takeda Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Takeda Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Enzyme Inhibitors Product Offerings
Table 84. Pfizer Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. Sanofi Company Summary
Table 87. Sanofi Enzyme Inhibitors Product Offerings
Table 88. Sanofi Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Sanofi Key News & Latest Developments
Table 90. Merck Company Summary
Table 91. Merck Enzyme Inhibitors Product Offerings
Table 92. Merck Enzyme Inhibitors Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Merck Key News & Latest Developments
Table 94. Enzyme Inhibitors Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 95. Global Enzyme Inhibitors Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Enzyme Inhibitors Production by Region, 2018-2023 (Units)
Table 97. Global Enzyme Inhibitors Production by Region, 2024-2029 (Units)
Table 98. Enzyme Inhibitors Market Opportunities & Trends in Global Market
Table 99. Enzyme Inhibitors Market Drivers in Global Market
Table 100. Enzyme Inhibitors Market Restraints in Global Market
Table 101. Enzyme Inhibitors Raw Materials
Table 102. Enzyme Inhibitors Raw Materials Suppliers in Global Market
Table 103. Typical Enzyme Inhibitors Downstream
Table 104. Enzyme Inhibitors Downstream Clients in Global Market
Table 105. Enzyme Inhibitors Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Enzyme Inhibitors Segment by Type in 2022
Figure 2. Enzyme Inhibitors Segment by Application in 2022
Figure 3. Global Enzyme Inhibitors Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Enzyme Inhibitors Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Enzyme Inhibitors Revenue, 2018-2029 (US$, Mn)
Figure 7. Enzyme Inhibitors Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Enzyme Inhibitors Revenue in 2022
Figure 9. By Type - Global Enzyme Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Enzyme Inhibitors Revenue Market Share, 2018-2029
Figure 11. By Type - Global Enzyme Inhibitors Sales Market Share, 2018-2029
Figure 12. By Type - Global Enzyme Inhibitors Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Enzyme Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Enzyme Inhibitors Revenue Market Share, 2018-2029
Figure 15. By Application - Global Enzyme Inhibitors Sales Market Share, 2018-2029
Figure 16. By Application - Global Enzyme Inhibitors Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Enzyme Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Enzyme Inhibitors Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Enzyme Inhibitors Revenue Market Share, 2018-2029
Figure 20. By Region - Global Enzyme Inhibitors Sales Market Share, 2018-2029
Figure 21. By Country - North America Enzyme Inhibitors Revenue Market Share, 2018-2029
Figure 22. By Country - North America Enzyme Inhibitors Sales Market Share, 2018-2029
Figure 23. US Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Enzyme Inhibitors Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Enzyme Inhibitors Sales Market Share, 2018-2029
Figure 28. Germany Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 29. France Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Enzyme Inhibitors Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Enzyme Inhibitors Sales Market Share, 2018-2029
Figure 37. China Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 41. India Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Enzyme Inhibitors Revenue Market Share, 2018-2029
Figure 43. By Country - South America Enzyme Inhibitors Sales Market Share, 2018-2029
Figure 44. Brazil Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Enzyme Inhibitors Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Enzyme Inhibitors Sales Market Share, 2018-2029
Figure 48. Turkey Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Enzyme Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 52. Global Enzyme Inhibitors Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Enzyme Inhibitors by Region, 2022 VS 2029
Figure 54. Enzyme Inhibitors Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 酵素阻害剤の世界市場見通し2023年-2029年(Enzyme Inhibitors Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

酵素阻害剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp